SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 261.50 |
Enterprise Value ($M) | 225.49 |
Book Value ($M) | 121.19 |
Book Value / Share | 3.93 |
Price / Book | 2.16 |
NCAV ($M) | 112.62 |
NCAV / Share | 3.65 |
Price / NCAV | 2.32 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.48 |
Return on Assets (ROA) | -0.35 |
Return on Equity (ROE) | -0.38 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 9.75 |
Current Ratio | 9.75 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 129.69 |
Assets | 138.26 |
Liabilities | 17.07 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | -67.10 |
Net Income | -60.39 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -42.64 |
Cash from Investing | 50.72 |
Cash from Financing | -1.55 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Perceptive Advisors Llc | 17.40 | 78.23 | |
13D/A | Ra Capital Management, L.p. | 27.10 | 73.52 | |
13G/A | Citadel Advisors Llc | 7.40 | ||
13G/A | Marshall Wace North America L.P. | 2.70 | -51.16 | |
13G/A | Sands Capital Ventures, LLC | 7.40 | -0.00 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
Form 10-Q | ||
Form 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
28,383 | 90,418 | 31.39 | |
134,018 | 154,501 | 86.74 | |
23,612 | 70,911 | 33.30 | |
56,721 | 69,656 | 81.43 | |
34,296 | 56,085 | 61.15 | |
(click for more detail) |
Similar Companies | |
---|---|
ACAB – Atlantic Coastal Acquisition Corp. II | ACET – Adicet Bio, Inc. |
ACIU – AC Immune SA | ADMA – ADMA Biologics, Inc. |
ALIM – Alimera Sciences, Inc. |
Financial data and stock pages provided by
Fintel.io